Last edited by Dogore
Friday, May 8, 2020 | History

3 edition of Drug resistant neoplasms found in the catalog.

Drug resistant neoplasms

Drug resistant neoplasms

  • 133 Want to read
  • 24 Currently reading

Published by Nova Science in Hauppauge, N.Y .
Written in English

    Subjects:
  • Drug resistance in cancer cells,
  • Drug Resistance, Neoplasm

  • Edition Notes

    Statementeditor, Ethan G. Verrite.
    ContributionsVerrite, Ethan G.
    Classifications
    LC ClassificationsRC271.C5 D778 2009
    The Physical Object
    Paginationp. ;
    ID Numbers
    Open LibraryOL23614265M
    ISBN 109781607412557
    LC Control Number2009026399
    OCLC/WorldCa368045867

    Search Articles. Enter search terms. Keep search filters New search. Digestive system cancer remains a common cancer and the main cause of cancer‐related death worldwide. Drug resistance is a major challenge in the therapy of digestive system cancer, and represents a primary obstacle in the treatment of cancer by restricting the efficiency of both traditional chemotherapy and biological by: 2.

    Search Articles. Enter search terms. Keep search filters New search. Advanced search. Help. neoplasms - drug therapy () Filter by: Remove filter drug resistance, neoplasm () Filter by: Remove filter: growth () Filter by.   1. Int J Cancer. Jan 15;(2) The involvement of hypoxia-inducible factor-1alpha in the susceptibility to gamma-rays and chemotherapeutic drugs of Cited by:

    HT29 cells resistant to oxaliplatin and both HT29 and HCT cells resistant to docetaxel were characterized for their expression of genes potentially involved in drug resistance, cell growth and cell division, and by surveying stem cell-like phenotypic traits, including marker genes, the ability to repair cell-wound and to form by: Summary: This book serves as a single source for the current knowledge on genetic and epigenetic alterations that contribute to the development of drug resistance in cancer cells. Comprehensive reviews written by renowned experts provide great insight on the current knowledge on drug resistance .


Share this book
You might also like
Parliamentary control in the Nordic countries

Parliamentary control in the Nordic countries

Why We Are Here

Why We Are Here

A diffuse murmur of history

A diffuse murmur of history

works of Nicholas Ridley, D.D., sometime Lord Bishop of London, martyr, 1555

works of Nicholas Ridley, D.D., sometime Lord Bishop of London, martyr, 1555

politics of health policy

politics of health policy

China mission

China mission

Publications of the U.S. Geological Survey, Water Resources Division, for Puerto Rico and the U.S. Virgin Islands, 1899-1992

Publications of the U.S. Geological Survey, Water Resources Division, for Puerto Rico and the U.S. Virgin Islands, 1899-1992

Catalogue of a collection of Walt Whitman literature

Catalogue of a collection of Walt Whitman literature

Gaffer Samsons luck

Gaffer Samsons luck

Bibliotheck

Bibliotheck

Heads of Mr. Buckinghams lectures on the eastern world

Heads of Mr. Buckinghams lectures on the eastern world

Bridge across the Delaware River, Wilmington, Del.

Bridge across the Delaware River, Wilmington, Del.

mystery of men.

mystery of men.

Drug resistant neoplasms Download PDF EPUB FB2

Drug Resistant Neoplasms (Cancer Etiology Diagnosis and Treatment Series) UK ed. Edition Drug resistant neoplasms book Ethan G. Verrite (Editor)Author: Ethan G. Verrite. The purpose of this book is to explore new concepts related to drug resistance in cancer, including resistance to the new molecularly targeted agents.

Perhaps new terminology is needed for resistance that occurs following therapy with the targeted agents: Novel Targeted Agent Resistance (NTR).Format: Hardcover.

- Neoplasma " an excellent book that is appropriate for scientists and clinicians with an interest in the basis of anticancer drug resistance.". -Doody's Book Review, Weighted Numberical Score: 90 - Format: Hardcover. The book explores all of these issues, including the phenomenon of epithelial-mesenchymal-transition, cancer stem cells as well as microRNAs in an attempt to better understand the disease in connection to its heterogeneity/metastasis/drug-resistance as well as to propose novel signaling pathways for therapeutic : Hardcover.

Bristol-Myers Cancer Symposia, Volume 9: Mechanisms of Drug Resistance in Neoplastic Cells provides information on both basic scientific and clinical studies on the causes and implications of tumor cell resistance to common antineoplastic agents. 'Superbugs' Book Chronicles Rise Of Antibiotic-Resistant Pathogens NPR's Don Gonyea speaks with Dr.

Matt McCarthy about his book Superbugs: The Race to Stop an hy explains how these. The Genetic Origin of Drug Resistance in Neoplasms: Implications for Systemic Therapy 1'n1 Divisions of Advanced Therapeutics [J.

G.] and Epidemiology and Biometry [A. C.], Cancer Control Agency of Cited by: The Killers Within is a nonfiction book about drug-resistant bacteria. As you read the novel, many different references are made to many significant doctors. Some of which include the CDC, the FDA, and the national government's measures to prevent these strains of bacteria from reproducing/5.

This book presents a thorough and authoritative overview of the multifaceted field of antibiotic science – offering guidance to translate research into tools for prevention, diagnosis, and treatment of infectious diseases.

Provides readers with knowledge about the broad field of drug resistance. When reporting an infection other than Staphylococcus aureus, that is antibiotic resistant, report the infection first followed by a code from category Z16, Infection with drug resistant microorganisms Infection with drug resistant microorganisms T/F.

True. When the histological type of neoplasm is documented, reference the Alphabetical. Cytotoxic Drug Resistance Mechanisms (Methods in Molecular Medicine) th Edition by Robert Brown (Editor), Uta Böger-Brown (Editor) ISBN ISBN Why is ISBN important. ISBN. This bar-code number lets you verify that you're getting exactly the right version or edition of a book.

Format: Hardcover. Start studying ATI Pedi Book Ch 40 Blood Neoplasms. Learn vocabulary, terms, and more with flashcards, games, and other study tools.

Med Princ Pract. ;14 Suppl Mechanisms of drug resistance in cancer chemotherapy. Luqmani YA(1). Author information: (1)Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Kuwait University, Kuwait. [email protected] The management of cancer involves procedures, which include surgery, radiotherapy and by: Drug resistant neoplasms.

[Ethan G Verrite;] -- "One of the main causes of failure in the treatment of cancer is the development of drug resistance by the cancer cells.

The design of cancer chemotherapy has become increasingly sophisticated, yet. This page lists cancer drugs approved by the Food and Drug Administration (FDA) for myeloproliferative neoplasms.

The list includes generic names, brand names, and common drug combinations, which are shown in capital letters.

The drug names link to NCI's Cancer Drug Information summaries. Purchase Mechanisms of Drug Resistance in Neoplastic Cells - 1st Edition. Print Book & E-Book. ISBNBook Edition: 1. CHAPTER 4 Chapter-specific guidelines (ICDCM chapters ) What will be the initial challenges for implementing ICDCM.

“Training, training, and training of physicians and staff. Because the structure of ICD is more specific and the codes look different, the mindset has to change. Documentation must be even more detailed than before.”. a) "Drug therapy will continue until all symptoms of tuberculosis have stopped." b) "You can expect to take multiple drugs possibly for as long as 24 months or until all tubercle bacilli are eliminated." c) "Drug therapy will continue unless a drug resistance develops." d) "You will be on multiple drug.

Resistant mutations frequently occur at the drug binding site of the targeted kinases In this study, we identified five different point mutations in the kinase domain of JAK2VF in an in vitro screen that conferred resistance to the ATP competitive JAK2 inhibitor ruxolitinib and cross-resistance to CYT, TG, AZD and Cited by: COVID Resources.

Reliable information about the coronavirus (COVID) is available from the World Health Organization (current situation, international travel).Numerous and frequently-updated resource results are available from this ’s WebJunction has pulled together information and resources to assist library staff as they consider how to handle coronavirus.

This chapter provides guidance on the strategies for the treatment of multidrug- and extensively drug-resistant TB (M/XDR-TB), with emphasis on regimen design.

The treatment of mono- and poly-drug-resistant TB is addressed in Chapter 6. The strategies described in this chapter are largely based on the recommendations from the update of Guidelines for the programmatic management of drug.lung neoplasms - drug therapy () Filter by: Remove filter: dose-response relationship, drug () Filter by: Remove filter: kinases () Filter by: Remove filter: drug resistance, neoplasm - drug effects () Filter by: Remove filter: survival ()   In the EUROPEAN UNION, antibiotic resistance cau deaths per year and m extra hospital days [1] In INDIA, o babies died in one year as a result of infection with resistant bacteria usually passed on from their mothers [2] In THAILAND, antibiotic resistance cau+ deaths per year and m hospital days [3].